Association of β-Amyloid Level, Clinical Progression, and Longitudinal Cognitive Change in Normal Older Individuals

OBJECTIVE: To determine the effect of β-amyloid (Aβ) level on progression risk to mild cognitive impairment (MCI) or dementia and longitudinal cognitive change in cognitively normal (CN) older individuals. METHODS: All CN from the Australian Imaging Biomarkers and Lifestyle study with Aβ PET and ≥3...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Kall, Laura M., Truong, Thanh, Burnham, Samantha C., Doré, Vincent, Mulligan, Rachel S., Bozinovski, Svetlana, Lamb, Fiona, Bourgeat, Pierrick, Fripp, Jurgen, Schultz, Stephanie, Lim, Yen Y., Laws, Simon M., Ames, David, Fowler, Christopher, Rainey-Smith, Stephanie R., Martins, Ralph N., Salvado, Olivier, Robertson, Joanne, Maruff, Paul, Masters, Colin L., Villemagne, Victor L., Rowe, Christopher C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884996/
https://www.ncbi.nlm.nih.gov/pubmed/33184233
http://dx.doi.org/10.1212/WNL.0000000000011222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884996/
https://www.ncbi.nlm.nih.gov/pubmed/33184233
http://dx.doi.org/10.1212/WNL.0000000000011222

Ejemplares similares